ATS 2026: PABPC4 gene identified as a key driver of emphysema in COPD

Pharmaceutical Technology

PABPC4 genetic variants found to be associated with mitochondrial dysfunction driving emphysema in COPD.

pharminent May 21, 2026 (Last updated: May 21, 2026)

Pharmaceutical Technology

PABPC4 genetic variants found to be associated with mitochondrial dysfunction driving emphysema in COPD.

Related Stories